Seasoned pharma R&D executive with 23 years of international experience in EU, Australia and N. America. Extensive discovery to approval expertise with protein, peptide, oligonucleotide and small molecule drugs. Devised & commissioned R&D/Quality operations for three high growth Co. Lead R&D programmes for multiple approved products and a key member of senior management for three successful IPO’s

Sylvain Guénetteis Chief Financial Officer of Labopharm Inc. Prior to joining Labopharm, Mr. Guénette was Corporate Controller at Les Systèmes Proxima Ltée from August 2001 to August 2002. From 1999 to 2001, he was Director of finance and operations of the Montreal Office of Nurun Inc. and held various positions within the Quebecor group from 1994 to 1999.

Corinne Benquet PhD has over 14 years experience in the biotechnology/pharmaceutical industry, with extensive experience in early development projects. She has managed and implemented research and development programs for numerous molecules and therapeutic areas including oncology, endocrinology, analgesia and depression. Corinne held different progressive positions at Compatigène, Conjuchem Biotechnologies, Aurelium Biopharma and Labopharm